A recent study showed reductions in preterm birth and admissions in neonatal intensive care units after individualized management in cases of preterm premature rupture of membranes.
ndividualized management may help prolong pregnancy and reduce preterm birth in cases of preterm premature rupture of membranes (PPROM), according to a recent study.
About 3% of pregnancies lead to PPROM. The condition is most often treated through expectant management, such as antenatal steroids for lung maturation and prophylactic antibiotic treatment. Investigators sought to analyze the results of management strategies for PPROM.
The multicenter retrospective study consisted of 513 women with singleton pregnancies, having experienced PPROM within 23 to 33 weeks of gestation. A standard management group of 324 individuals was given similar management to other patients, while an individualized management group of 189 individuals was given personalized management based on amniocentesis upon hospital admission. Of the 189 patients receiving individualized management, 112 were given amniocentesis.
Exclusion criteria for the individualized management included major fetal anomalies, contraindications to expectant management, active labor, and cervical dilatation greater than 2 centimeters. Latency of over 7 days was the primary outcome, while secondary outcomes included chorioamnionitis, latency to birth, and short-term adverse maternal and neonatal outcomes.
The patients with individualized management had a latency of over 7 days, and higher latency to birth. Investigators suspected that these patients also had a higher rate of clinical chorioamnionitis, but no higher rate of histologic chorioamnionitis was found, nor were there differences in funisitis, or composite infectious maternal outcomes.
A reduction of preterm birth at under 32 weeks of gestation was seen in cases of prolonged latency in the individualized management group, as well as a reduction in neonatal intensive care unit admission and neonatal respiratory support at 28 days of life. Prolonged latency also led to fewer cases of neonatal severe morbidity at discharge.
Reference
Ronzoni S, Cobo T, D’Souza R, Barret J, Aldecoa V, Palacia M, et al. Individualized treatment of preterm premature rupture of membranes to prolong the latency period, reduce the rate of preterm birth, and improve neonatal outcomes. American Journal of Obstetrics Gynecology. 2022;227(2):296.E1-296.E18. doi:10.1016/j.ajog.2022.02.037
This article originally appeared on Contemporary Pediatrics®.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More